Dopamine miracle: From brain homogenate to dopamine replacement

Movement Disorders

Volumn 17, Issue 3, 2002, Pages 501-508

  Hornykiewicz, Oleh ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; RESERPINE;

ARTICLE; BASAL GANGLION; BRAIN HOMOGENATE; CAUDATE NUCLEUS; DOPAMINE METABOLISM; DOPAMINE RELEASE; DRUG ACTIVITY; DRUG EFFECT; HUMAN; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; SUBSTANTIA NIGRA;

ANIMALS; DOPAMINE; DOPAMINE AGENTS; HISTORY, 20TH CENTURY; HUMANS; PARKINSON DISEASE; PORTRAITS;

EID: 0036589897     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10115     Document Type: Article

References (12)

1. Hornykiewicz O. A quarter century of brain dopamine research. In: Woodruff GN, Poat JA, Roberts PJ, editors. Dopaminergic systems and their regulation. London: Macmillan; 1986:3-18.
2. Blaschko H. Metabolism and storage of biogenic amines. Experientia 1957;13:9-12.
3. Hornykiewicz O. The action of dopamine on the arterial pressure of the guinea pig. Brit J Pharmacol 1958;13:91-94.
4. Montagu KA. Catechol compounds in rat tissues and in brains of different animals. Nature 1957;180:244-245.
5. Carlsson A, Lindqvist M, Magnusson T, Waldeck B. On the presence of 3-hydroxytyramine in brain. Science 1958;127:471.
6. Bertler Å, Rosengren E. Occurrence and distribution of dopamine in brain and other tissues. Experientia 1959;15:10-11.
7. Sano I, Gamo T, Kakimoto Y, et al. Distribution of catechol compounds in human brain. Biochim Biophys Acta 1959;32:586-587.
8. Bertler Å, Rosengren E. On the distribution in brain of monoamines and of enzymes responsible for their formation. Experientia 1959;15:382-383.
9. Ehringer H, Hornykiewicz O. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin Wschr 1960;38:1236-1239.
10. Birkmayer W, Hornykiewicz O. Der L-Dioxyphenylalanin (= DOPA)-Effekt bei der Parkinson-Akinese. Wien Klin Wschr 1961;73:787-788.
11. Hornykiewicz O. Dopamine and Parkinson's disease. A personal view of the past, the present, and the future. Adv Neurol 2001;86: 1-11.
12. Raab W, Gigee W. Concentration and distribution of "encephalin" in the brain of humans and animals. Proc Soc Exp Biol Med 1951;76:97-100.